Adaptive Biotechnologies Corporation and Flatiron Health have announced the integration of Adaptive's clonoSEQ® test for measurable residual disease (MRD) assessment into Flatiron's OncoEMR® ...

March 10, 2026) - R3 Bio announced the release of its 2026 research report outlining early-stage progress in developing integrated, stem cell-derived biological platforms designed to reduce reliance ...

Artificial intelligence algorithms are being built into almost all aspects of health care. They’re integrated into breast cancer screenings, clinical note-taking, health insurance management and even ...

Pickering Interfaces, the leading supplier of modular signal switching and simulation solutions for use in electronic test and verification, has announced Test System Architect, a free online ...